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The fifth component of complement (C5) has been shown to play a key role in 
the biological actions of the complement system (1, 2). As yet unresolved, how- 
ever,  is the mode of action of C5  in immune cytolysis. Earlier  studies  in this 
laboratory led to the formulation of two alternative hypotheses for the mecha- 
nism of action of C5 (3). The "sequential action hypothesis" proposed that C5, 
C6, and C7 act in sequence with the formation of a  cellular intermediate  after 
each reaction step. The "functional unit hypothesis" proposed that C5, C6, and 
C7 act in concert as interdependent members of a single functional unit. It was 
not possible to choose between these hypotheses since experimental data in sup- 
port of each was obtained. 
This  paper  presents  evidence  which  indicates  that  C5  may  act  through 
specific attachment to cells which have reacted with the first four complement 
components (EAC 1,4,2,3). It delineates the conditions of formation of a hemo- 
lyrically active  C5 intermediate  complex,  the physical fate  of C5 in this reac- 
tion,  and  the  occurrence of at  least  five different functional forms of  the  C5 
molecule. Evidence will also be presented which shows that the cellular uptake 
of C5 and, hence,  its hemolytic efficiency are greatly enhanced by C6 and C7. 
The simultaneous existence of two distinct pathways for C5 in immune hemoly- 
sis will be discussed. 
Materials and Methods 
Human Complement Components.--Highly purified C2 (4, 5), C3 (6), C4 (7), and C5 (6), 
and partially  purified C1 (8), C6, and C7 (9) were isolated from human serum by published 
techniques. The activity of C2 was enhanced by oxidation with iodine as previously described 
(10), Preparations of C2, C3, C4, and C5 were trace-labeled with t~Siodine by the chloramine-T 
method  (11) with full retention  of hemolytic activity.  The 12 preparations  of ~25I-C5 used 
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in these studies had an average specific activity of 1.8  X  105 cpm//.~g, a value which corre- 
sponds to 0.115 /zCi//~g.  Following Pevikon block electrophoresis, the labeled preparations 
showed an identical distribution of protein, radioactivity, and hemolytic activity. Additional 
tests performed to show that the labeled molecules were representative of the entire popula- 
tion of molecules in a  given preparation included neutralization-competition tests and  ag- 
glutination-inhibitlon tests. In the latter technique, C5 uptake by cells was estimated by a 
method  independent  of  radioactivity  measurement.  EAC1,4,2,3,125I-C5,  bearing  1850 
specifically  bound C5 molecules per cell by radioactivity measurement, were added to dilu- 
tions of a monospecific antiserum to C5 in order to determine the agglutination end point. 
Next, an amount of purified, unlabeled C5 equal to the product of the number of radioactively 
labeled C5 molecules per cell times the number of cells, was added to dilutions of the anti- 
serum which bracketed the previously determined end point. After a  period of incubation, 
the EAC1,4,2,3,125I-C5 were added. The agglutination titer was reduced by one twofold 
dilution. In simultaneous experiments incubation with twice the above amount of unlabeled 
C5  reduced the agglutination end point by two double dilutions. Since the amount of un- 
labeled  C5  added  was determined by  nitrogen  analysis,  these studies indicated excellent 
agreement between  the  results  obtained  by  radioactivity measurement and  by  immuno- 
chemical analysis. 
Preparation qf Serum Reagent Containing C6,  C7,  C8, and  C9.--Guinea  pig  serum  was 
incubated with an equal volume of cold 1 ~t KSCN for 16-18 hr at 4°C in order to inactivate 
C3,  C4, and C5 in the serum (12). The mixture was then treated for 45 min at 37°C with a 
final concentration of 1.5  X  10  -2 ~  hydrazine hydrate, a reagent which also inactivates C3, 
C4, and C5. After extensive dialysis at 4°C against veronal-buffered NaC1, pH 7.4, the treated 
serum was frozen. For use in the effective molecule titration of C5,  the serum was thawed 
and diluted 1 : 100 in 0.04 ~t EDTA in veronal-buffered NaC1. This reagent produced a con- 
stant level of hemolysis of EAC1,4,2,3,5, bearing a limited number of C5 sites to a dilution 
of 1: 200. 
Labeling of Erythrocytes with Radioactive Chromium.--15  ml of sheep erythrocytes (E), 1 
5 )<  10S/ml in veronal-buffered NaC1, were incubated with 500/zCi of 51Cr-so~um chromate 
(13)  for 45  min at 37°C.  The cells were then washed five  times in veronal-buffered NaC1, 
pH 7.4,  transferred to a clean tube, and washed again prior to use.  The erythrocytes were 
indistinguishable from unlabeled E  with respect to  reactivity with antibody and  C1,  C2, 
C3,  C4,  and  C5.  Determinations of free hemoglobin by  spectrophotometer and  by  51Cr- 
measurement gave identical values for percentage of ]ysis  of EACI,4,2,  and EAC1,4,2,3 
in the presence of the remaining components. 
Preparation  of  Sheep  Erythrocyte-Antibody-Complement  Complexes.--The  preparation 
of  EAC1  (8),  EAC1,4  (5),  EAC1,4,2  (5),  and  EAC1,4,2,3  (14) has  been  described. 
EAC1,4,2,3 for C5 titration and uptake studies were prepared as follows. EAC1,4, bearing 
approximately 3000  specifically  bound C4 molecules per cell,  were formed by the addition 
to EAC1 of 200 effective molecules of C4 per cell (100/zg/5 )<  109 EAC1). Following restora- 
tion of C1  (5), the EAC1,4 were reacted with 50 effective molecules of oxidized C2 per cell, 
a dose which is sufficient to saturate the bound C4 molecules (5). After incubation for Tmax 
time and washing, 500 #g of C3 per 5 >(  109 cells were added. This amount of C3 results in 
the specific binding of approximately 25,000 C3 molecules per cell.  EAC1,4°xy2,3, bearing 
known  numbers  of  C4,2  sites  per  cell,  were  prepared  from  EAC1,1~5I-C4.  Each 
lot of EAC1,125I-C4,  bearing a  known number of radiolabeled C4 molecules per cell,  was 
reacted sequentially with sufficient  °xyc2 to saturate the C4 sites (5)  and a constant excess 
of C3. 
1 Abbreviations used in this paper: E, sheep erythrocytes; Tmax, time at  which there is 
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Effective Molecule Titration of C5.--EAC1,4,2,3  in EDTA-GVB  (veronal-buffered NaC1, 
pH 7.4, containing 0.1% gelatin and 0.01 ~  EDTA [14]) at a concentration of 1.5 X  10S/ml 
were dispensed in 0.2 ml portions in a series of tubes. Then, 0.2 ml of EDTA-GVB, followed 
by 0.2 ml of dilutions of C5, were added and the tubes incubated with shaking at 30°C. After 
a  predetermined optimal period of reaction  (Tmax), which was usually  about  10 rain, 2.4 
ml of a  1:100 dilution of KSCN hydrazine-treated guinea pig serum in 0.04 ~  EDTA-GVB 
were  added.  Mter  1 hr of  incubation at 37°C,  the tubes were centrifuged and the optical 
density of the supernatant solutions was determined at 412 m/~ on a  Beckman DU spectro- 
photometer  (Beckman Instrument Co.,  Fullerton,  Calif.).  Controls included,  in duplicate, 
EAC1,4,2,3  plus KSCN-hydrazine guinea pig serum (control 1),  a KCNS-hydrazine serum 
color blank (control 2)  and a water lysate of the cells.  The optical density of control 1 was 
subtracted  from  that of  the  experimental tubes,  while the difference between  the  optical 
densities of controls 1 and 2 was subtracted from the 100% lysis value. The corrected reading 
for each experimental tube was then divided by the corrected 100% lysis value to obtain the 
proportion of cells lysed  (y). The degree of lysis, when plotted against the dilution of C5, 
describes a curve which is concave toward the dose scale. This relationship may be converted 
to one of direct proportionality when the reciprocal of the negative natural logarithm of the 
unlysed cells,  i.e.  1/-In(I-y)  (16),  is graphed arithmetically against the reciprocal of the dilu- 
tion of C5. As the -ln(1-y) value expresses the average number of effective C5 sites per cell 
(17),  a  --ln(1-y) value of unity indicates one C5 site or one effective molecule of C5 per cell. 
Multiplication of the reciprocal of the dilution producing a  --ln(1-y) value of unity by the 
number of cells gives the number of effective molecules present in the sample containing C5. 
Quantitation of Uptake of Radioactively Labeled C5.--Prior to use, crystalline human serum 
albumin (Behringwerke A. G., Marburg-Lahn, Germany) was added to the 125I-C5 preparation 
to a final concentration of 1 mg/ml in order to prevent aggregation of the labeled preparation 
which occurs on pipetting. The preparations were then centrifuged for 20 rain at 2000 g to re- 
move any preformed aggregates of C5. Uptake studies were performed under conditions identi- 
cal to those employed for the effective molecule titration of C5, except that the volume of all 
reagents was increased 2.5-fold. Mter completion of the lyric period, the tubes were centrifuged 
and the supernatant fluids were analyzed for released hemoglobin. The cells and stromata of 
each of the reaction mixtures were washed four times at 4°C, transferred to clean tubes, and 
analyzed for radioactivity in a well-type scintillation counter. In some experiments C5 uptake 
was terminated at Tmax by centrifugation and washing of the cells. The samples were then di- 
vided into two portions, one of which was added to the C6-9 reagent in order to determine 
the hemolytic activity of bound C5;  the other was analyzed for radioactivity. Nonspecific 
uptake of C5 was determined in all studies from reaction mixtures identical to those employed 
for  the  titration  of  C5,  except  that  E,  EA,  EAC1,4  or  EAC1,4,2  were  substituted 
for  EAC1,4,2,3.  Specific  uptake  was  obtained  by  subtracting the  values for  nonspecific 
uptake from the total bound radioactivity. Nonspecific binding of C5 averaged 20% of the 
total radioactivity and thus was considerably higher than has been observed in studies with 
any  of  the  other  complement proteins.  Although nonspecifically adsorbed  C5  was  firmly 
bound, cells bearing only nonspecifically bound C5 were not agglutinated by antisera to C5. 
A tool wt of 2 X  105 was used to calculate the number of bound C5 molecules. The percentage 
of uptake of C5 was calculated from the linear portion of a  graph of  125C5 input against 
specific 125I-C5 uptake. 
Determination of the Hemolytic Efficiency of Cell-Bound CS.--The  supernatant fluids of 
the reaction mixtures used to determine the uptake of 12~I-C5 were saved and analyzed for 
released hemoglobin. The hemolytic values, expressed as 1/-In(I-y), obtained for the cells 
prepared from each dilution of  125I-C5, were plotted  arithmetically against the reciprocal 
of the number of specifically bound 12~I-C5 molecules per cell,  as determined from the radio- 
active uptake  values.  The number of  cell-bound  C5  molecules necessary to  produce  one 
hemolytically effective molecule was obtained from the graph at a  --ln(1-y) value of unity. 778  HUMAN  C5  REACTION MECHANISM 
C5  Transfer Studies.--Varying numbers of washed EAC1,4,2,3,5,  termed donor cells, 
were added to 0.2 ml of 1.5 X  10S/ml EAC1,4,2,3, termed recipient cells. In order to permit 
differentiation of the lysis produced by the two cell  types, one of the cell  types, generally 
the recipient cells, was labeled with ~]Cr. The cell mixtures were centrifuged and resuspended 
in 50 #1 of EDTA-GVB and, after 10 min of shaking at 30°C, 0.55 ml  of EDTA-GVB and 
2,4 ml of 1:100  C6-9 reagent were added.  After 60 rain at 37°C  the reaction mixtures were 
centrifuged and the optfcal density and radioactivity of the supernatant fluids were deter- 
mined. The percentage of lysis of the recipient cells was obtained by quantitating the release 
of radioactivity. From the spectrophotometrically and radioactively determined hemoglobin 
release, the percentage of lysis of the donor cells was calculated. 
Neutralization-Competitlon Tests.---This technique was introduced by  Stroud et  al.  (18) 
as an analytical method for detecting and studying hemolytically inactive products of C2. 
In the present study this test was used to detect hemolytically inactive C5 eluted from cells. 
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Fio.  1.  Tmax of C5. Kinetics of formation of a C5 intermediate complex. Equal volumes 
of C5  (0.01/zg/ml) and EAC1,4, °xy2,3 (1.5 X  10S/ml)  were incubated at 30°C.  Duplicate 
samples were taken  at  intervals, one of which was added  directly to  the C6-C9  reagent 
(not washed), while the cells in the other sample were washed prior to addition to the lyric 
reagent (washed). 
A preparation of C5 having an identical hemolytic activity to protein ratio in labeled and 
unlabeled forms was used to prepare EACI,4, oxy2,3,5. The same dose,  1.4  X  105  mole- 
cules per cell, of both forms of C5 was also added to EAC1,4 as a control for nonspecifically 
bound C5.  These cell preparations were centrifuged after 45  min at  30°C,  and  the super- 
natant fluids were analyzed for eluted, hemolytically inactive C5.  Varying amounts of the 
supernatant fluids were added to 2.32 effective molecules of C5. Next, a dilution of antibody 
to  C5  capable of neutralizing the hemolytic activity of 1.05 effective molecules of C5  was 
added.  After 60  min at  37°C,  the mixtures were titrated for hemolytically active C5.  An 
increase in  the amount of active C5  indicated the presence of inactive C5  in the reaction 
mixture. The number of molecules of inactive C5  necessary to produce a given increase in 
free active C5 was determined by calculation, assuming that active and inactive C5 reacted 
equally well with anti-C5. 
RESULTS 
Formation of a C5 Intermediate Complex and the Fate of Fluid-Phase C5.-- 
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to  variable  results,  various  parameters  of  the  reaction  of  C5  with 
EAC1,4°*y2,3 were analyzed. In order to characterize the kinetics of the reac- 
tion, a mixture of C5 and EAC1,4, °~y2,3 was incubated at 30°C. Periodically, 
duplicate samples were removed, one of which was added directly to the C6-9 
reagent, while the cells in the other sample were washed twice at 0°C prior to 
their addition to the lytic reagent. Fig. 1 shows the kinetics of formation and 
decay of a C5 intermediate complex. 
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Fro. 2.  Fate of C5 upon reaction with EAC1,4,2,3. Association of C5 binding with the 
formation of a hemolyticaUy active C5 intermediate complex and inactivation of C5 in the 
fluid phase. Equal volumes  of lz~I-C5  (0.46 /zg/ml)  and EAC1,4,°xy2,3  (1.5 X  108/ml) 
were incubated at 30°C. Residual C5 activity was measured in the supernatant fluid of sam- 
ples taken at intervals (supernatant), while the cells in each sample were washed and analyzed 
for cell-bound  C5 radioactivity (bound  ]esI-C5)  and hemolytic activity (cell bound). Cell- 
bound hemolytic activity was measured  indirectly: The washed cells from each sample were 
placed at 30°C and the loss of C5 activity as a function to time was determined. By extra- 
polation of the decay curve, the number of effective molecules of C5 per cell at the times 
of the original samples was obtained. 
In  order  to  determine  whether  the  acquisition of  C5  activity  was  accom- 
panied by physical attachment of C5 to the ceils, a similar experiment was per- 
formed with radiolabeled C5.  Samples were taken at  intervals and the cells in 
each  of  the  samples,  after  four  washes  at 4°C,  were  examined  for  both  cell- 
bound C5 radioactivity and hemolytic activity. The supernatant fluid of each 
sample was saved and subsequently titrated for residual C5 hemolytic activity. 
Examination of the results of this experiment (Fig. 2) shows that the acquisition 
of C5  activity by the cells was correlated with the uptake of 12~I-C5. In addi- 
tion, maximal formation of EAC1,4,2,3,5  and maximal uptake of radioactively 780  HUMAN  C5  REACTION  MECHANISM 
labeled C5 occurred at the same time (Tmax). During the process of formation 
of EAC1,4,2,3,5, the hemolytic activity of unbound C5 in the fluid phase was 
rapidly lost. Since less than 10% of the C5 activity which disappeared from the 
fluid phase phase could be accounted for by cellular uptake, the loss must have 
been due to inactivation without binding. 
The Role of C4,2 and C3 in the Binding and Activation  of C5.--In order to 
investigate the influence of the number of C4,2 molecu__~les  per cell on C5 uptake, 
EAC1,125I-C4, °xY2,3, bearing known numbers of C4,2 molecules per cell, were 
mixed with a single lu5I-C5 preparation. A linear relationship was found to pre- 
vail between the number of bound C4,2 molecules per cell and the uptake of C5, 
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FIG. 3. Dependence  of C5 uptake on the number of C4-~ molecules  per cell. The uptake of 
125I-C5 by EAC1,12~I-C4,  °xY2,3 was determined with cells which varied 1000-fold in the 
number of 125I-C4-~ molecules  per cell. 
when these results were expressed logarithmically (Fig. 3). Each 10-fold incre- 
ment in the number of C4,2 molecules per cell, over a 1000-fold range, produced 
a 4-fold increase in  the uptake of C5.  A  similar linear relationship prevailed 
when the effective molecule titer of a single C5 preparation was determined with 
several  batches  of  EACI,I~sI-C4,°xy2,3,  bearing  known  numbers  of  C4,2 
molecules per cell.  In this instance, however, the resulting linear relationship 
showed that each 10-fold increase in the number of C4,2 molecules per cell was 
reflected in a 25-fold increase in the effective molecule titer of the C5 prepara- 
tion. 
Essentially identical studies were performed with EAC1,4, °xy2,125I-C3, bear- 
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creasing numbers of 125I-C3 molecules per cell. A linear relationship existed be- 
tween the number of C3 molecules per cell and the uptake and effective mole- 
cule titer of the C5 preparation.  Each 10-fold  increment in the number of C3 
molecules per cell produced a 3-fold increase in the uptake of C5 and a  7-fold 
increase in its hemolytic activity. 
It is apparent that a constant titer or uptake of C5 is not achieved even with 
very large numbers of C4,2 and C3 molecules per assay cell. Therefore, in sub- 
sequent studies EAC1,4,2,3, bearing approximately 3000 C4,2 molecules and 
25,000 C3 molecules per cell, have generally been used. 
°-81 L  ~  °°c  ¥  II  ~  ,/2:7o' 
.I  ~  \  C5 
T/,o,' 
0.2"t  I  C5 
I  ~  37°c 
I  V/2 = 2.3' 
2'0  4'0 
Minutes 
FIG. 4. Lability of the hemolytic  activity of bound C5. EAC1,4,°xy2,3,5 were incubated 
at 0°C, 300C, or 37°C and sampled at intervals for residual cell-bound C5 activity. Complete 
lysis was observed on testing the cells for °xyc2 activity throughout the period of study. 
Lability of the Hemolytic Activity of Bound C5.--Fig. 4 shows the rate of loss of 
bound C5 activity on EAC1,4,°xy2,3,5 as a function of time and temperature. 
The half-life of bound C5 at 30°C in 20 determinations was 8-10 rain,  and at 
37°C it was 2.3  rain.  In many experiments a  second linear  component of the 
decay curve was observed after 20-30 rain of incubation at 30°C. This second 
phase, of unknown significance,  had a half-life of 16-20 rain at 30°C. 
Is Decay of Cell-Bound  C5 Activity Due to Dissociation  of C5 Protein from 
EAC1,4,2,3,5?--Dissociation  of C5 protein from EAC1,4,2,3,5 as the possi- 
ble cause of the ]ability of bound C5 activity was explored using radiochemical 
techniques and the neutralization-competition method. The intermediate com- 
plexes  EAC1,4,2,3,5,  EACI,°xY2,3,5 and EAC1,4,°xY2,3,5,6,7  were pre- 
pared with radioactively labeled C5; 125I-C5 was also incubated with EAC1,4 as 782  tIUMAN  C0  REACTION  MECHANISNI 
a control for nonspecifically adsorbed C5. At Tmax the cells were centrifuged, 
washed, and placed at 30°C. The cells in samples taken at intervals were washed 
and  the cell-bound radioactivity determined and corrected for nonspecifically 
bound C5. Very little loss of bound 125I-C5 occurred over a 2 hr period (Fig. 5), a 
conclusion further substantiated  by the finding of less than  10%  of the  total 
radioactivity in the supernatant fluid of the 2 hr sample. It should be noted that 
the functional status of C2 and the presence of C6 and C7 had no influence on 
the very slow elution of bound C5. C5 protein readily binds nonspecifically to 
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FiG. 5.  Release of C5 from various intermediate complexes. Intermediate complexes bear- 
ing 125I-C5 were incubated at 30°C; cells bearing nonspecifically bound C5  (EAC1,4 +  C5) 
were also included. Samples were taken at intervals and the cells, after washing, were analyzed 
for bound radioactivity. Dissociation of either specifically  or nonspeciflcally bound C5  was 
minimal. 
cells, as shown by the high levels of uptake by EAC1,4. This form of C5 also re- 
mained firmly bound. 
The neutralization-competition technique was employed in order to rule out a 
difference in dissociation behavior of labeled and unlabeled C5. In these experi- 
ments C5 cells were prepared with radioactive and nonradioactive C5. The two 
intermediates were comparable with respect to bound C5, as they gave identical 
end points with dilutions of antibody to C5. Measurements of cell-bound radio- 
activity showed 1930  C5 molecules per cell  at the onset of the experiment and 
1780 molecules per cell after 45 min of incubation, indicating a release of 8 % of 
the  bound  1~I-C5.  Analyses  of  the  supernatant  fluids  indicated  that 
EAC1,4,°xy2,3,~25I-C5  released sufficient hemolytically inactive C5  in 45 min N.  R.  COOPER  AND  H.  J.  MULLER-EBERHARD  783 
to produce an increase of 0.29 effective molecules of active C5 in the neutraliza- 
tion-competition test, while the supernatant of cells prepared with unlabeled C5 
produced an increase of 0.16 effective molecules of active C5. No release of non- 
specifically bound C5 was detected. If it is assumed that native and cell-disso- 
ciated C5 react equally well with antibody to C5, the above values correspond 
respectively to the release of 490 and 240 molecules of labeled and unlabeled C5 
per cell in 45 rain at 30°C. Thus,  the neutralization-competition  test detected 
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FIG. 6. Release of C2 from various intermediate complexes. Intermediate  complexes bear- 
ing either native or oxidized 125I-C2 were incubated  at 30°C and periodically sampled for 
residual cell-bound C2 radioactivity.  Oxidized C2 was released at a low rate from the inter- 
mediate complexes tested.  Native C2 dissociated from each of the three complexes with an 
initial half-time of 10 rain. 
release of 25 %  of the total of bound 125I-C5 in 45 min incubation at 30°C and 
showed that there was little difference between labeled and unlabeled C5 in this 
regard. These studies show that dissociation of C5 from C5 cells does occur, but 
at a rate which is not sufficiently rapid to explain the rapid loss of C5 hemolytic 
activity from EAC1,4,2,3,5. 
Is Decay of Cell-Bound C5 Activity Due to Dissociation of C2 from EAC1,4,2, 
3,5?--The complexes EAC1,4,2, EACI, 4,2,3, EAC1,4,2,3,5,  and EAC1,4, 
2,3,5,6,7 were prepared separately with 125I-C2 in both untreated and oxidized 
forms.  The  cell  preparations  were  washed,  placed  at  30°C,  and  periodically 
sampled. Fig. 6 reveals that oxidized 125I-C2 was firmly bound to all cell types 
examined.  In the same experiment unoxidized  C2 was found to elute with an 784  HUMAN  C5  REACTION  MECHANISI~I 
initial half time of 10 min at 30°C which coincides with its hemolytic half time 
at this temperature. Thus,  the lability of bound  C5  activity could not be ex- 
plained by dissociation of C2. Fig. 7 reveals that this lability was also not due to 
alteration of the functional status of C2. 
Molecular Size of Cell-Bound C5.--To determine the approximate size of cell- 
bound C5, cells bearing 12~I-C5 were incubated in a concentrated suspension for 
3 hr at 37°C  and the supernatant fluid, containing about 30%  of the original 
cell-bound  C5,  was analyzed by ultracentrifugation  in a  sucrose gradient.  As 
shown  in  Fig.  8,  native and cell-dissociated  C5  exhibited  a  comparable sedi- 
mentation behavior. 
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FIG.  7.  Effect of C5 on cell-bound °xYC2.  EAC1,4,°xY2 were prepared with limited °xyc2 
(1.1 effective molecules/cell) and the cells were subsequently exposed to an excess of C3 (2  ;K 
105 molecules/cell) and C5 (5.6 X  104 molecules/cell). The cells were then washed, placed at 
30°C, and periodically sampled for residual C2 activity. The slow rate of loss of bound °xyc2 
activity was independent of the presence or absence of C5 on the cells. 
Hemolytic Efficiency of CS.--In order to  analyze the binding efficiency of C5, 
effective molecule fitrations were carried out with 1~5I-C5 and following comple- 
tion of the lyric period the cells and stromata were washed and analyzed for 
12~I-C5 uptake. Fig. 9 shows the effective molecule titration of a C5 preparation 
obtained with EAC1,4,°xy2,3  bearing approximately 3000 C4,2 sites per cell. 
A -ln(1 -- y) value of unity occurred at a 1:24,000 dilution; however, when the 
cells were washed at Tmax prior to the addition of C6-9, ten times more C5 was 
required to produce the same degree of lysis. Fig. 10 shows the relationship be- 
tween 125I-C5 input and uptake obtained in this experiment. The specific uptake 
of C5 obtained from the linear portion of the curve was 0.88 % of input. When 
binding of C5 was determined in the absence of the C6-9 reagent, the uptake was 
only 0.18%. The results of six uptake experiments are shown in Table I. Even 
with very large numbers of C4,---2 and C3 molecules per cell,  uptake was maxi- 
mally 4 % of input. N.  R.  COOPER  AND  H.  J.  MULLER-EBERHARD  785 
Fig.  11  shows the effective molecule titration  as a  function of the number  of 
bound  C5  molecules per  cell,  A  -ln(1  --  y)  value  of unity  occurred  with  five 
specifically bound molecules of C5 per cell. When C5 was bound in the absence 
of C6-9, -ln(1  -- y)  =  1 occurred with 12 molecules per cell. Table I  summarizes 
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Fzo.  8.  Sucrose  density  gradient  ultracentrifugation  of  C5  dissociated  from  C5  cells. 
EAC 1,4, oxy2,3,5 and EAC 1,4, °xy2,3,5,6,7, prepared with 125i.  C 5, were incubated in con- 
centrated  suspensions  for 3  hr  at  37°C.  Mter  centrifugation,  the  supernatant  fluids were 
analyzed by ultracentrifugation. Fraction 1 represents the bottom of the centrifuge tube. 
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FI6.  9.  Effective molecule  titration  of  a  preparation  of  125I-C5 (No.  5).  The  protein 
concentration of this preparation was 0.720 mg/ml. The titer was reduced 10-fold when the 
titration was interrupted  by a  series  of washes after the C5  reaction step  (beund  without 
C6-C9). 786  HUMAN  C5  REACTION  MECHANISM 
the results of six studies of the hemolytic efficiency of bound C5. An average of 
seven bound  C5  molecules were required  to cause lysis of a  cell,  regardless of 
whether C5 was bound in the presence or absence of C6-9. It is apparent, there- 
fore, that the effect of the C6-9 reagent is confined to increasing the uptake of 
C5, not to the hemolytic efficiency of bound C5. 
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FIG.  10.  Relationship between input of 125I-C5  (No. 5) and its specific cellular uptake by 
EAC1,4, °xy2,3. The C5 preparation  and cells are  the same as those shown in Figs. 9  and 
11.  Uptake of C5 was enhanced approximately 5-fold by the presence of C6-C9. 
TABLE  I 
Efciency~fBindingand HemolyticEffciency ~ Bound125I-C5EAC1,4,°xv2,3  +  125I-C5 
C6-9 added later  C6-9 present 
Experiment  A  B  C  A  B  C 
No.  % uptake of  Bound Mole-  Hemolytic  % uptake of  Bound mole-  Hemolytic 
t~zi.C  5  cule/Effective  efficiency  l~5i_C  5  cule/effective  efficiency 
Molecule  t00/A X B  molecule  100/A X B 
1  0.02  9  45000  0.6  12  2000 
2  0.2  12  6000  0.9  5  560 
3  0.8  4  500  3.0  5  166 
4  1.1  8  730  3.5  5  143 
5  0.5  1  200  3.3  3  90 
6  0.5  1  200  3.9  3  77 
Effect of C6 and C7 on the Binding of C5.--As indicated above (Fig. 10, Table 
I), the uptake and, hence, the hemolytic activity of C5 were markedly reduced 
when the reaction of C5 with EAC1,4,2,3  was carried out in the absence of 
C6-C9. Because of the known physicochemical interaction between C5, C6, and 
C7  in free solution (2), 2 the effect of C6 and  C7 on the uptake of 125I-C5 was 
2 GStze, O., and H. J. Miiller-Eberhard.  Lysis of erythrocytes by complement in  absence 
of antibody. J. Exp. Med. In press. N.  R.  COOPER  AND  tI.  J.  NlfJLLER-EBERI-IARD  787 
explored. As shown in Fig. 12,  the presence of C6 and C7 increased the uptake 
of 125I-C5 in direct proportion to the amount  of these components  offered. In 
this experiment the maximal increase of C5 uptake produced by C6 and C7 was 
approximately fourfold. 
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FIG. 11.  Hemolytic efficiency of cell-bound  12~I-C5 (No. 5). Relationship between  effec- 
tive molecules of 12~I-C5 and the number of specifically bound  125I-C5 molecules per cell. 
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FIG. 12. Effect of C6 and C7 on the uptake of 125I-C5. Increasing amounts of a pool of C6 
and C7 were added to a mixture of 125I-C5 and EAC1,4,°xY2,3. Mter 60 min at 37°C, the 
cells were washed and C5 uptake was determined. 
The Question of Cell-to-Cell Transfer  of Activated CS.--Shin,  Pickering,  and 
Mayer  (19)  have  shown  that  incubation  of  a  mixture  of  EAC1,4,2,3  and 
EAC1,4,2,3,5  renders both cell types susceptible to lysis by C6-9. They have 
interpreted this as indicating cell-to-cell transfer of activated C5. The following 
experiments, however,  make  necessary a  different interpretation  of  this  phe- 
nomenon. EAC1,4,°xY2,3,5 were added in varying numbers to 3  X  l0  T cells of 
different 51Cr-labeled intermediate complexes. After incubation for  10 rain  at 788  HUMAN  C5  REACTION  MECHANISM 
30°C in a total volume of 50 #1 of EDTA-GVB, C6-9 was added. In this experi- 
ment,  EAC1,4,°xY2,3,5  alone  were  92%  lysed.  Upon  admixture  with  ~Cr- 
EAC1,4,°xy2,3  (Fig.  13),  however,  there  was  an  absolute  increment  in  free 
hemoglobin  due  to lysis  of 51Cr-EAC1,4,°xY2,3.  Lysis  and  51Cr release  were 
proportional  to the number of EAC1,4,°xY2,3,5  cells present.  This effect was 
specific for EAC1,4,°~Y2,3 as recipient cells, as neither EAC1,4,°'~Y2, EAC1,4 
nor E  were hemolysed.  It should be emphasized  that  the  amount  of lysis  of 
EAC1,4,°xy2,3,5  obtained in these studies was unchanged in the presence of 
other cell types. Identical results were also obtained when EAC1,4, °xy2,3,5,6, 
7 were used as donor cells for C5. 
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Fla. 13. Lysis of EAC 1,4, °xy2,3 in the presence of EAC 1,4, °xy2,3,5 and C6-C9. Varying 
numbers  of EAC1,4,°xy2,3,5 were added to 3 X  106 cells of different  51Cr-labeled inter- 
mediate complexes, and after  10 min at 30°C, C6-C9 was added. EAC1,4,°xy2,3 were lysed 
in proportion  to the number of C5 cells present in the same reaction mixtures. The C5 cells 
were 92% lysed by C6-C9 whether tested alone or in the presence of other cell types. 
The results of the above studies, in particular the observation that lysis of the 
donor cells was not reduced in the presence of recipient cells,  tended to negate 
transfer of activated C5 as responsible for the lysis of EAC1,4,°xy2,3. An alter- 
native explanation was then considered, namely that this phenomenon is due to 
the utilization of nonspecificallyadsorbed, native C5 and not to transfer of acti- 
vated  C5. This hypothesis was verified in the following experiments.  Unsensi- 
tized red cells (E)  were incubated with three amounts of C5 for 10 rain at 30°C. 
These E  +  C5 cells were thoroughly washed and added to EAC1,4,°xy2,3 in 
experiments identical  to those described earlier.  As shown in Fig. 14,  the E  + 
C5 cells were able to donate C5 to EAC1,4,°xY2,3 and thus were able to com- 
pletely duplicate the results obtained earlier with EAC1,4, °xy2,3,5. The E  + 
C5  cells  were  not  lysed  in  this  reaction,  which  was  specific  in  that  only 
EAC1,4, °xY2,3  cells could serve as recipient cells and EAC1,4, °xY2, EACI, 4~ 
and E  could not. N.  R.  COOPER  AND  H.  J.  MULLER-EBERIIARD  789 
DISCUSSION 
These experiments were initiated to clarify the mode of action of C5 in im- 
mune hemolysis. The studies presented here show that a small proportion of C5 
offered to EAC1,4,2,3 becomes specifically cell bound (Figs. 2, 10) in a cytolyt- 
ically active form  (Fig.  11).  It is thus clear that the fifth reaction step may 
proceed via the formation of a hemolytically active cellular intermediate com- 
plex, as proposed by the sequential action hypothesis (2). The extent of forma- 
tion of the C5 intermediate complex was found to be controlled by cell-bound 
C4,2 and C3 with each increment in the number of C4,2 or C3 molecules per 
cell being reflected in greater binding of C5 (Fig. 3). Although only a minor pro- 
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FIG. 14. Utilization of C5 adsorbed to E in lysis of EAC1,4,2,3 by C6-C9. Nonsensitized E 
were incubated with varying amounts of C5 (E +  C5), washed, and added to 5tCr-EAC1,4, 
°xy2,3 and other cellular intermediate complexes. C6-C9 was then added. The line shows the 
lysis of C3 cells obtained; neither C4 cells, C2 cells, nor E were lysed in mixtures with E +  C5 
(control). 
portion of the C5 offered to EAC1,4,2,3  became physically cell bound,  all of 
the C5 participated in the reaction as evidenced by its time-dependent loss of 
activity in the fluid phase. These data, along with the observation that C5  is 
cleaved by EAC4,2,3  (20), indicate that the C5 reaction step is mediated by a 
cell-bound complement enzyme, most likely C4,2,3 (21). It is probable that the 
C5 intermediate is formed by a process of activation-transfer-binding identical 
to that postulated for the reaction steps involving C2 (5), C3 (14)  and C4 (22). 
The hemolytic activity of the C5 intermediate complex was found to be labile 
(Fig. 4), a feature which characterizes the C5 step as potentially rate-limiting in 
the complement reaction. While it was initially felt, in comparison with the C2 
step, that the lability was probably secondary to dissociation of C5 from the 
cells,  this hypothesis could not be verified. Experiments with radiolabeled C5 
(Fig. 5) as well as neutralization-competition tests failed to show sufficient elu- 790  HUMAN  C5  REACTION  MECHANISI~ 
tion of C5 protein to explain the lability of bound C5 hemolytic activity. Nor 
could the lability be attributed to elution of °xyC2 from EAC1,4, °xY2,3,5 (Fig. 
6) or to a change in the functional status of bound C2 (Fig. 7). Therefore, the 
loss of activity of bound C5 must be a property of the C5 molecule itself. Since 
the majority of C5 molecules do not dissociate from cells,  C5 must undergo a 
change in situ which renders it hemolytically unreactive. Although the nature of 
this alteration is unknown, it is not correlated with a major change in the size of 
the molecule (Fig. 8). 
While the above studies show that the C5 reaction step may progress via the 
formation of an intermediate complex in a  manner analogous to the reaction 
mechanism of the other complement components (1), the  C5 step is unique in 
that it may also proceed via an alternative pathway.  This alternate mechanism 
of C5 action was suggested by studies which showed that C5  uptake and hemo- 
lyric activity were markedly enhanced when the C5 reaction step  was carried 
out in the presence of C6-C9 (Table I). Further study showed  that isolated C6 
and C7 greatly increased the uptake and, hence, hemolytic activity of C5 (Fig. 
12, Table I). This alternative pathway, in which C5,  C6, and C7 act  together, 
probably explains the formation of EC5,6,7  which occurs when a mixture of 
unsensitized erythrocytes (E),  C3,  C5,  C6,  and C7  is treated with preformed 
C4,2  (23). As shown in this laboratory (23  and footnote 2), neither a  C5 nor 
C5,6 intermediate complex with E can be formed, the sinmltaneous presence of 
C5,  C6, and C7 being necessary. Lachmann and Thompson, in studies of reac- 
tive hemolysis (24), have found that C5 and C6 form a complex after activation 
which  is  unable  to bind  to E  unless  C7  is  supplied.  Under these conditions, 
EC5,6,7  is formed. While the simultaneous requirement for all three compo- 
nents for binding mav be related to the ability of these components to form a 
protein-protein complex (3), the underlying mechanism of the alternative path- 
way is unknown. 
Despite the enhancement of C5 uptake produced by C6 and C7, the efficiency 
of binding of C5 remained low in comparison to that observed with other com- 
ponents (1). Even with cells bearing large numbers of C4,2 and C3 molecules per 
cell,  the uptake remained less than 4 % of input (Table I). This relative ineffi- 
ciency of  binding  was  offset,  however,  by  the  exceptionally high  hemolytic 
efficiency of bound C5. An average of 7 bound C5 molecules per cell were suffi- 
cient to produce 63 % lysis (Table I), i.e., one effective molecule per cell. When 
determined with cells bearing large numbers of C4,2 and C3 molecules per cell, 
the efficiency was even more striking, with only three molecules per cell being 
required  (Table I).  Since the data conform to the one-hit theory of imnmne 
hemolysis  (17),  the  interpretation  is  that  one of these bound molecules pro- 
duces a single lesion which results in lysis. Thus, in contrast to the results ob- 
tained in studies of the hemolytic efficiency of bound C2 (5), C3 (1) and C4 (8), 
relatively few molecules of C5 appear to be specifically bound at sites on the cell 
surface which are resistant to complement injury. N.  R.  COOPER  AND  I-I. J.  M/)LLER-EBERtlARD  791 
The C5 molecule is unique among the complement proteins in that it is readily 
adsorbed in native form to various intermediate complexes (Fig. 5) as well as to 
unsensitized erythrocytes. This nonspecifically bound C5  remains firmly at- 
tached,  although it may be  specifically utilized as a  source of native C5  by 
EAC1,4, 2,3 (Fig. 14) in an ongoing complement reaction. 
These studies document the existence of at least five functional forms of the 
C5 molecule. These include: (a)  native C5 present in serum,  (b)  C5 which is 
found adsorbed in apparently native form to erythrocytes (Fig. 14), (c) bound 
active C5 which is responsible for the hemolytic activity of the C5 intermediate 
complex,  (d)  unbound,  inactive  C5  which  has  entered  into  reaction  with 
EAC1,4,2,3 but failed to become bound, and (e) bound, inactive C5 which has 
lost its hemolytic activity while remaining firmly attached. 
SUMMARY 
The data presented here indicate that the C5 reaction step may proceed via 
the specific attachment of C5 to EAC1,4,2,3 and the formation of a hemolyt- 
ically active C5 intermediate complex. During this process only a minor propor- 
tion (less than 4%) of C5 offered to EAC1,4,2,3 becomes bound, although the 
remaining C5 also participates in the reaction as evidenced by its inactivation in 
the fluid phase. Once bound, C5 is exceptionally efficient in producing hemolysis, 
requiring less than seven specifically bound molecules per cell for the production 
of a hemolytic lesion. The extent of formation of the C5 intermediate complex is 
primarily dependent on the number of molecules of C4,2 and C3 present on the 
cells employed for its generation. In these respects, the mode of action of C5 is 
completely analogous to that of the other components of complement thus far 
investigated. The C5 step differs, however, in other aspects. The binding of C5 
is influenced by C6 and C7, components which are thought to act subsequent to 
it in the complement sequence. In addition, the hemolytic activity of the iso- 
lated C5 intermediate complex is exceedingly labile, having an average half-life 
at 30°C of only 9 rain. This characteristic distinguishes the C5 step, along with 
the C2 step, as potentially rate-limiting in the complement reaction. However, 
unlike C2,  C5 remains firmly cell-bound during the decay process and appar- 
ently undergoes an alteration in situ which renders it hemolytically unreactive. 
Finally, C5 is unique in that it readily adsorbs in native form to unsensitized 
erythrocytes. This nonspecificMly bound C5 remains firmly attached, although 
it may be specifically utilized as a source of C5 by an ongoing complement re- 
action. The significance of the marked affinity of native C5 for ceU-surface recep- 
tors remains to be determined. 
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